Wednesday, October 1, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Leadership Changes at Fossil Group Inc A Strategic Shift Towards Growth and Transformation

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
DrugRetailers Trading online
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Fossil Group, Inc. underwent significant leadership changes on March 13, 2024. Jeffrey N. Boyer was appointed as the Interim CEO and Director, replacing Kosta N. Kartsotis who resigned as Chief Executive Officer and Board member. Kevin Mansell, the Lead Independent Director of the Board, was named as the Chairman of the Board.

Jeffrey N. Boyer, with over 30 years of retail experience, has been a key member of Fossil Group’s leadership team since 2017, previously holding positions as Chief Operating Officer and Chief Financial Officer. Meanwhile, Kevin Mansell brings more than 40 years of retail industry experience to his new role as Chairman of the Board, having previously served as Chairman, CEO, and President of Kohl’s Corporation until his retirement in 2018.

These leadership changes signify a strategic shift for Fossil Group as they continue to progress with their Transform and Grow Plan and seek a permanent CEO to guide the company into the future.

Fossil Group Inc. (FOSL) Stock Sees Slight Increase on March 13, 2024: Whats Next for Investors?

On March 13, 2024, Fossil Group Inc. (FOSL) saw a slight increase in its stock performance. The stock closed at $0.87, which was a $0.01 increase from the previous market close, representing a 1.03% rise. Additionally, in after-hours trading, FOSL shares rose by an additional $0.02.

Despite these gains, FOSL is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This suggests that the stock may not be experiencing strong upward momentum compared to its historical performance.

Investors and analysts will likely continue to monitor FOSL’s stock performance closely to assess its potential for future growth. The recent uptick in the stock price may be a positive sign for shareholders, but it remains to be seen whether this momentum will be sustained in the long term.

Fossil Group Inc. (FOSL) Stock Performance Review: Mixed Results Revealed

On March 13, 2024, Fossil Group Inc. (FOSL) stock experienced mixed performances based on the latest financial data released by the company. Total revenue for the past year was reported at $1.68 billion, showing a decrease of 10.03% compared to the previous year. However, there was a 6.88% increase in total revenue compared to the previous quarter.

The net income for the past year was reported at -$44.16 million, indicating a significant decrease of 273.61% compared to the previous year. In the most recent quarter, the net income was reported at -$61.06 million, showing a decrease of 130.17% compared to the previous quarter.

Earnings per share (EPS) for the past year were reported at -$0.85, representing a decrease of 276.76% compared to the previous year. In the most recent quarter, the EPS was reported at -$1.16, showing a decrease of 129.64% compared to the previous quarter.

Overall, the financial performance of Fossil Group Inc. as reflected in the latest data shows a mixed picture. While there was a slight improvement in total revenue compared to the previous quarter, the significant decreases in net income and EPS raise concerns about the company’s financial health and ability to generate sustainable profits. Investors should closely monitor future financial reports and market trends to assess the company’s potential for growth and profitability in the long term.

Tags: FOSL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

scPharmaceuticals Reports Strong Fourth Quarter 2023 Financial Results

Biotechnology Trading online

Needham Analyst Reiterates Buy Rating and 28 Price Target for Liquidia Technologies

Biopharmaceutical Stock Market Today (1)

Title Poseida Therapeutics Receives Orphan Drug Designation for PBCMAALLO1 Targeting Multiple Myeloma

Recommended

Motorola Stock

Motorola Solutions Strengthens Defense Technology Position Through Strategic Acquisitions

3 weeks ago
Honeywell Stock

Honeywell Faces Legal Challenge Following Air India Crash

1 week ago
Healthcare Services Stock Exchange

HCA Healthcare Reports Impressive Fourth Quarter Earnings and Sales Growth

2 years ago
IonQ Stock

Quantum Computing Stock Slips Despite Strategic Board Appointment

14 hours ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Gold Reaches Unprecedented Highs Amid US Political Turmoil

Leadership Purchases Signal Strong Confidence in Deutz AG

Thyssenkrupp’s Strategic Gamble: Can a Naval Powerhouse Rescue the Parent Company?

Sudden CFO Departure Sends Redcare Pharmacy Shares Tumbling

Idorsia Shares Surge on Heavy Trading Volume

Deutsche Telekom Launches Major Share Buyback Initiative

Trending

Valneva Stock
Analysis

Valneva Shares Surge on Breakthrough Vaccine Data

by Andreas Sommer
October 1, 2025
0

Investors are celebrating a major turnaround for Valneva as the biopharmaceutical company released compelling long-term results for...

Covestro Stock

Covestro Shares Surge as ADNOC Acquisition Nears Approval

October 1, 2025
Novo Nordisk Stock

Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

October 1, 2025
Gold Stock

Gold Reaches Unprecedented Highs Amid US Political Turmoil

October 1, 2025
Deutz AG Stock

Leadership Purchases Signal Strong Confidence in Deutz AG

October 1, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Valneva Shares Surge on Breakthrough Vaccine Data
  • Covestro Shares Surge as ADNOC Acquisition Nears Approval
  • Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com